Table 1. Clinicopathologic Characteristics of 103 Participants with 103 Observations.
Participants | n = 103 |
---|---|
Mean age | 63.1 (21–86) |
Sex | |
Male:female | 81:22:00 |
Cause of liver diseases | |
Hepatitis B virus | 67 (65) |
Hepatitis C virus | 6 (5.8) |
Alcohol | 11 (10.7) |
Others | 19 (18.3) |
Known cirrhosis | 45 (43.7) |
Child-Pugh classification | |
A | 95 (92.2) |
B | 8 (7.8) |
AFP level (ng/mL)* | 8.2 (1.1–7466) |
PIVKA (mAU/mL)* | 35 (11–43913) |
Observations | n = 103 |
Size (mm) | 28.2 (11–114) |
10–19 | 58 (56.3) |
≥ 20 | 45 (43.7) |
CT/MRI LI-RADS category | |
LR-3 | 5 (4.9) |
LR-4 | 21 (20.4) |
LR-5 | 60 (58.3) |
LR-M | 17 (16.5) |
Final diagnosis | |
HCC | 79 (76.7) |
Non-HCC malignancy | |
cHCC-CC | 2 (1.9) |
IHCC | 11 (10.6) |
Angiosarcoma | 1 (1) |
Metastasis | 1 (1) |
Benign | |
Dysplastic nodule | 3 (2.9) |
Adenoma | 2 (1.9) |
Regenerative nodule | 1 (1) |
Hemangioma | 1 (1) |
Focal nodular hyperplasia | 1 (1) |
Organizing hematoma | 1 (1) |
Reference standard for diagnosis | |
Pathological diagnosis | 57 (55.3) |
Noninvasive | 45 (43.7) |
Typical image features with more than 1-year stability† | 1 (1) |
*Median value, †Only for diagnosing hemangioma that presented peripheral globular enhancement pattern on CT and MRI with stability (> 1-year). AFP = alpha-fetoprotein, cHCC-CC = combined hepatocellular-cholangiocarcinoma, HCC = hepatocellular carcinoma, IHCC = intrahepatic cholangiocarcinoma, LI-RADS = Liver Imaging Reporting and Data System, LR = LI-RADS, PIVKA = protein induced by vitamin K absence or antagonist